Fairness-Aware Partial-label Domain Adaptation for Voice Classification of Parkinson's and ALS
Abstract
Domain fit: Niche / domain-specific · No strong AI-core implementation/artifact signals were detected from current providers.
Voice-based digital biomarkers can enable scalable, non-invasive screening and monitoring of Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS). However, models trained on one cohort or device often fail on new acquisition settings due to cross-device and cross-cohort domain shift. This challenge is amplified in real-world scenarios with partial-label mismatch, where datasets may contain different disease labels and only partially overlap in class space. In addition, voice-based models may exploit demographic cues, raising concerns about gender-related unfairness, particularly when deployed across heterogeneous cohorts. To tackle these challenges, we propose a hybrid framework for unified three-class (healthy/PD/ALS) cross-domain voice classification from partially overlapping cohorts. The method combines style-based domain generalization with conditional adversarial alignment tailored to partial-label settings, reducing negative transfer. An additional adversarial gender branch promotes gender-invariant representations. We conduct a comprehensive evaluation across four heterogeneous sustained-vowel datasets, spanning distinct acquisition settings and devices, under both domain generalization and unsupervised domain adaptation protocols. The proposed approach is compared against twelve state-of-the-art machine learning and deep learning methods, and further evaluated through three targeted ablations, providing the first cross-cohort benchmark and end-to-end domain-adaptive framework for unified healthy/PD/ALS voice classification under partial-label mismatch and fairness constraints. Across all experimental settings, our method consistently achieves the best external generalization over the considered evaluation metrics, while maintaining reduced gender disparities. Notably, no competing method shows statistically significant gains in external performance.
Results and benchmarks
Voice-based digital biomarkers can enable scalable, non-invasive screening and monitoring of Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS).
Benchmark evidence is limited
Evidence graph: 2 refs, 1 links.
Utility signals: depth 60/100, grounding 58/100, status medium.
Implementation
No direct implementation yet
Maintained implementation evidence is not confirmed for this paper yet.
Use the implementation status and reproduction sections for the current action plan.
No verified maintained repo yet
There is no verified maintained implementation yet. Use this baseline plan to decide whether to prototype now or defer.
- No direct maintained implementation was found. Use the paper PDF and citation graph to design a baseline reproduction.
- Track assumptions and missing details in an experiment log before coding.
Time to first repro: a few days
Recommendation evidence is currently too limited for a maintained-repo choice. Use Implementation Status and Reproduction Path for a practical baseline plan.
- Estimate is based on paper-only reproduction flow
Reproduction readiness
No repo
No verified implementation available
- No maintained repository has been identified for this paper. Check adjacent implementations or HF artifacts below.
Hardware requirements
- Expect multi-day setup/compute for meaningful reproduction based on current guidance.
Validation caveat
Hugging Face artifacts
No trustworthy direct or curated related Hugging Face artifacts were found yet. Use targeted searches to quickly locate candidate models, datasets, and demos.
Models
Datasets
Tip: start with models, then check datasets and spaces if you need evaluation data or demos.
Research context
Open this paper in HFEPX to review benchmark signals, evaluation modes, and human-feedback protocol context.
Open in HFEPX